Altered Expression and Function of P-Glycoprotein (170 Kda), Encoded by the MDR 1 Gene, in T Cell Subsets from Aging Humans
Tóm tắt
Aging is associated with progressive T cell-mediated immune deficiency, increased frequency of infections, and autoimmune phenomena. P-glycoprotein (P-gP), a 170-kDa glycoprotein, is a member of a superfamily of ATP-binding cassette transport proteins that has been shown to express on cells of the immune system and suggested to play a role in secretion of certain cytokines and cytotoxic molecules. Because aging is associated with altered secretion of cytokines, in this investigation we examined the expression and function of P-gP in CD4+ and CD8+ T cells and their “memory” and “naïve” subpopulations in peripheral blood from healthy aging and young subjects. P-glycoprotein expression was analyzed at the protein levels by dual- or triple-color flow cytometric analysis, using monoclonal antibodies against P-gP (MRK16), and at the mRNA level by quantitative reverse-transcriptase polymerase chain reaction. The efflux function of P-gP was measured by intracellular accumulation of rhodamine-123 (Rhl23; a substrate for P-gP) in the presence or absence of cyclosporin A (which binds to P-gP and inhibits its efflux function). The data show increased expression of P-gP at both the protein and the mRNA levels in aging lymphocytes. Increased P-gP expression, at the protein level, was also observed in naïve cell subpopulations from aging CD4+ and CD8+ T cell subsets compared to those from young controls. An increase in P-gP function, as measured by the ability of T cell subsets to efflux Rhl23, was observed in aging CD4+ and CD8+ T cell subsets and their naïve and memory subpopulations. These data suggest that altered P-gP expression and function in aging may play a role in changes in immune response, including cytokine secretion, associated with human aging.
Tài liệu tham khảo
Miller RA: Aging: Primer and prospectus. Science 273:70-76, 1997
Weksler ME: Immunology and the elderly: An historical perspective for future international action. Mech Age Dev 93:1-6, 1997
Nagel JE, Chopra RK, Chrest FJ, McCoy MT, Schneider EL, Holbrook NJ, Adler WH: Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors. J Clin Invest 81:96-109, 1988
Fernandes G, Gupta S: Natural killing and antibody-dependent cytotoxicity by lymphocyte subpopulations in young and aging humans. J Clin Immunol 1:141-148, 1981
Gupta S: Autologous mixed lymphocyte reaction in man. IX. Autologous mixed lymphocyte reaction and lymphocyte subsets in aging humans. Scand J Immunol 19:187-191, 1984
Gupta S: Membrane signal transduction in T cells in aging humans. Ann NY Acad Sci 568:277-282, 1989
Philosophe B, Miller RA: Diminished calcium signal generation in subsets of T lymphocytes that predominate old mice. J Gerontology 45:B87-B93, 1990
Saini A, Sai T: Age related impairment of early and late events of signal transduction in mouse immune cells. Life Sci 52:1759-1765, 1993
Ernst DN, Hobbs MV, Torbett BE, Glasebrook AL, Rehse MA, Bottomly K, Hayakawa K, Hardy RR, Weigle WO: Differences in the expression profiles of CD45RB, P-gp-1, and 3G11 membrane antigens in the patterns of lymphokine secretion by splenic CD4+ T cells from young and aged mice. J Immunol 145:1295-1302, 1990
Schwab R, Schmitt K: Dysregulated production of cytokines by CD4+ T cell subsets from aging humans. J Immunol 150:33A, 1993
Gottesman MM, Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385-427, 1993
Juranka PF, Zastawny RL, Ling V: P-glycoprotein: Multidrug resistance and a superfamily of membrane associated transport protein. FASEB J 3:2583-2592, 1989
Roninson IB: The role of MDR1 gene (P-glycoprotein) in multiple drug resistance in vitro and in vivo. Biochem Pharmacol 43:95-102, 1992
Wilson CM, Serrano AE, Wasely A, Bogneschutz MP, Shankar AH, Wirth DF: Amplification of a gene related to mammalian mdr genes in drug resistant Plasmodium falciparum. Science 244:1184-1186, 1989
Gollapudi S, Gupta S: Human immunodeficiency virus 1 (HIV-1)-induced P-glycoprotein expression. Biochem Biophys Res Commun 171:1002-1007, 1990
Gupta S: P-glycoprotein expression and regulation. Age-related changes and potential effects of drug therapy. Drugs Aging 7:19-29, 1995
Chaudhary PM, Roninson IB: Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoitic stem cells. Cell 66:85-94, 1991
Gupta S, Aggarwal S: P-glycoprotein in cells of the human immune system. Immunologist 4:86-90, 1996
Higgins CF: ABC transporters: From microorganisms to man. Annu Rev Cell Biol 8:67-113, 1992
Gupta S, Kim CH, Tsuruo T, Gollapudi S: Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in CD8+ T cells: A role in cytotoxic effector function. J Clin Immunol 12:451-458, 1992
Young PR, Krasney PA: Stimulation of interleukin 1b secretion in monkey kidney cells by coexpression of the mammalian P-glycoprotein MDR1. In Pathophysiology and Pharmacology of Cytokines, P Ghezzi, A Mantovani (eds). Augusta, GA, Biomedical Press, 1992, pp 21-27
Raghu G, Park SW, Roninson IB, Mechetner EB: Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes. Exp Hematol 24:1258-1264, 1996
Drach J, Gsur A, Hamilton G, Zhao S, Angerier J, Fiegl M, Zojer N, Raderer M, Haberi I, Andreeff M, Huber H: Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-γ in normal human T lymphocytes. Blood 88:1747-1754, 1996
Wilisch A, Noller A, Handgretinger R, Weger S, Nussler V, Niethammer D, Probst H, Gekeler V: Mdr1/P-glycoprotein expression in natural killer (NK) cells enriched from peripheral or umbilical cord blood. Cancer Lett 69:139-148, 1993
Hamada H, Tsuruo T: Functional role of the 170–180 kda glycoprotein specific to drug resistant tumor cells as treated by monoclonal antibodies. Proc Natl Acad Sci USA 83:7785-7789, 1986
Chomczynski P, Sacchi N: Single step method for RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
Aggarwal S, Gupta A, Tsuruo T, Gupta S: Differential expression of P-glycoprotein in cord blood and peripheral blood lymphocyte subpopulations. Int J Oncol 8:1063-1068, 1996
Kessel D, Beck WT, Kukuraga D, Schultz V: Characterization of multidrug resistance by fluorescent dyes. Cancer Res 51:4665-4670, 1991
Foxwell BMJ, Mackie A, Ling V, Ryffel B: Identification of multidrug resistance related P-gP as a cyclosporin binding protein. Mol Pharmacol 36:543-546, 1989
Saeki T, Ueda K, Tanigawara T, Hori R, Komano T: Human P-glycoprotein transports cyclosporin A and FK506. J Biol Chem 268:6077-6080, 1993
Gupta S, Gollapudi S: P-glycoprotein (MDR 1 gene product) in cells of the immune system: Its possible physiologic role and alteration in aging and human immunodeficiency virus-1 (HIV-1) infection. J Clin Immunol 13:289-301, 1993
Gupta S, Aggarwal S: Role of P-glycoprotein in the secretion of basic fibroblast growth factor. J Allergy Clin Immunol 95:345, 1995
Klimecki WT, Futscher BW, Grogan TM, Dalton WS: P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood 83:2451-2458, 1994
Hegewisch-Becker S, Fliegner M, Tsuruo T, Zander A, Zeller W, Hossfield DK: P-glycoprotein expression in normal and reactive bone marrows. Br J Cancer 67:430-435, 1993
Witkowski JM, Miller RA: Increased function of P-glycoprotein in T lymphocytes subsets of aging mice. J Immunol 150:1296-1306, 1993
Pilarski LM, Paine D, McElhaney JE, Cass CE, Belch AR: Multidrug transporter P-glycoprotein 170 as a differentiation antigen on normal human lymphocytes and thymocytes. Am J Hematol 49:328-335, 1995
Lee WY, Yin X-M, Vitteta ES: Functional and ontogentic analysis of murine CD45RB and CD45RB on CD4+ T cells. J Immunol 144:3288-3295, 1990
Bottomly K, Luqman M, Greenbaum L, Carding S, West J, Pasqualini T, Murphy DB: A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines. Eur J Immunol 19:617-623, 1989
Gabriel H, Schmitt B, Kindermann W: Age-related increase of CD45RO+ lymphocytes in physically active adults. Eur J Immunol 23:2704-2706, 1995
De Paoli P, Battinstin S, Santini GF: Age-related changes in human lymphocyte subsets: Progressive reduction of the CD4 CD45RA (suppressor inducer) population. Clin Immunol Immunopathol 48:290-296, 1988
Gupta S, Tsuruo T, Gollapudi S: Multidrug resistance gene 1 product in human T cell subsets: Role of protein kinase C isoforms and regulation by cyclosporin A. Adv Exp Med Biol 323:39-47, 1992
Chambers TC, McAvoy EM, Jacobs JW, Eilon G: Protein kinase C phosphorylates P-glycoprotein in multidrug resistant KB carcinoma cells. J Biol Chem 265:7679-7686, 1990
Abbaszadegan MR, Futscher BW, Klimecki WT, List A, Dalton WS: Analysis of multidrug resistance-associated protein (MRP) in normal and malignant hematopoitic cells. Cancer Res 54:4676-4679, 1994
Scheffer GL, Wijngaard PL, Flens MJ, Izquierdo MA, Slovak ML, Pinedo HM, Meijer CJLM, Clevers HC, Scheper RJ: The drug resistance-related protein LRP is the human major vault protein. Nature Med 1:578-582, 1995